MATERIALS AND METHOD
2. Berquin Patrick, Amiens
Le trouble déficitaire d’attention avec hyperactivité: aspects neuro-fonctionnels Pediatrica, Vol. 16 No. 6 20005
3. Biederman Joseph, MD; Faraone Stephen V, PhD; Monuteaux Michael C, ScD; and Grossbard Joel R, MA
How Informative Are Parent Reports of Attention-Deficit/Hyperactivity Disorder Symptoms for Assessing Outcome in Clinical Trials of Long-Acting Treatments? A Pooled Analysis of Parents’ and Teachers’ Reports
Pediatrics 2004;113;1667-1671 DOI:10.151427peds.113.6.1667 4. Greenhill Laurence
Attention-Deficit Hyperactivity Disorder: the Stimulants Child Adolesc Psychiatr Clinic North Am 1995;4:123-169
5. Markowitz John S, Pharm. D.; Straughn Arthur B, Pharm.D.; Patrick Kennerly S, Ph.D.
Advances in the Pharmacotherapy of Attention-Deficit-Hyperactivity Disorder: Focus on Methylphenidate Formulations
Pharmacotherapy Volume 23, Number 10, 2003
6. Brown Ronald T, Amler Robert W, Freeman Wendy S, Perrin James M, Stein Martin T, Feldman Heidi M, Pierce Karen, Wohlraich Mark L and the Committtee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder
Treatment of Attention-Deficit/Hyperactivity Disorder: Overview of the Evidence Pediatrics 2005;115;749-757
DOI:10.1542/peds.2004-2560
7. Pelham William E, Gnagy Elisabeth M, Burrows-Maclean Lisa, Williams Andy, Fabiano Gregory A, Morrisey Sean M, Chronis Andrea M, Forehand Gregory L, Nguyen Celeste A, Hoffman Martin T, Lock Thomas M, Fielbelkorn Karl, Coles Erika K, Panahon Carlos J, Steiner Randi L, Meichenbaum David L, Onyango Adia N and Morse Gene D
Once-A-Day Concerta Methylphenidate Versus Three-Times-Daily Methylphenidate in Laboratory and Natural Settings
Pediatrics 2001;107:e105 DOI:10.1542/peds.107.6.e105
Conlon Charles, Pearl Phillip L, Black David O, Seymour Karen E and Newcorn Jeffrey H
A Dose-response Study of OROS Methylphenidate in Children With Attention-Deficit/Hyperactivity disorder
Pediatrics 2003;112;404-13 DOI: 10.1542/peds.112.5.e404
9. Wohlraich Mark L, Greenhill Laurence L, Pelham William, Swanson James, Wilens Timothy, Palumbo Donna, Atkins Mark, McBurnett Keith, Bukstein Oscar, August Gerald and on Behalf of the Concerta Study Group
Randomized, Controlled Trial of OROS Methylphenidate Once a day in Children With Attention Deficit/Hyperactivity disorder
Pediatrics 2001;108;883-892 DOI:10.1545/peds.108.4.883
10. Fitzpatrick PA, Klorman R, Brumaqhim JT, Borgstedt AD
Effects of Sustained-Release and Standard Preparations of Methylphenidate on Attention-deficit Disorder
J Am Child Adolesc Psychiatry 1992;31(2):226-34
11. Pelham WE Jr, Greenslade KE, Vodde-Hamilton DA, Greenstein JJ, Gnagy EM, Guthrie KJ, Hoover MD, Dahl RE
Relative Efficacy of Long-acting Stimulants on Children with Attention deficit-Hyperactivity Disorder: a Comparison of Standard Methylphenidate, release Methyphenidate, Sustained-release Dextroamphetamine, and Pemoline
Pediatrics 1990;86(2):226-37
12. Whitehouse D, Shah U, Palmer FB
Comparison of Sustained-release and Standard Methylphenidate in the treatment of minimal brain dysfunction
J Clin Psychiatry 1980;41(8):282-5
13. Sustained-release Methylphenidate: New preparations. New pharmaceutical forms: a Slight Advantage for a Small Number of Children
Prescrire Int 2004;13(74):203-6
14. Lopez Frank, Silva Paul, Pestreich Linda and Muniz Rafael
Comparative Efficacy of Two Once Daily Methylphenidate Formulations (Ritalin®LA and Concerta®) and Placebo in Children with Attention Deficit Hyperactivity Disorder Across the School Day
Pediatr Drugs 2003; 5 (8), 545-555
Single- and Multiple-dose Pharmacokinetics of an Oral Once-a-day Osmotic Controlled-release OROS (Methylphenidate HCl) Formulation
J Clin Pharmacology 2000;40(4):379-88
16. Brown Ronald T, Freeman Wendy S, Perrin James M, Stein Martin T, Amler Robert W, Feldman Heidi M, Pierce Karen and Wohlraich Mark L
Prevalence and Assessment of Attention-Deficit/Hyperactivity Disorder in Primary Care Settings Pediatrics 2001;107;e43
DOI:10.1542/peds.107.3.e43
17. Swanson JM, Lerner M, Williams L
More Frequent Diagnosis of Attention-Deficit/Hyperactivity Disorder N Engl J Med. 1195;333:944
18. Klassen Anne F, Miller Anton and Fine Stuart
Health-Related Quality of Life in Children and Adolescents Who Have a Diagnosis of Attention-Deficit/Hyperactivity Disorder
Pediatrics 2004,114,541-547 DOI:10.1542/peds.2004-0844
19. Chhabildas Nomita, Pennington Bruce F, Willcut Erik G.
A comparison of the Neuropsychological Profiles of the DSM IV Subtypes of ADHD Journal of Abnormal Child Psychology, Vol. 29, No. 6, December 2001, pp. 529-540 20. Spencer T, Biederman J, Wilens T
Attention-Deficit/Hyperactivity Disorder and Comorbidity Pediatr Clin North Am1999;46:915-927
21. Di Scala Carla, Leschier Ilana, Barthel Martha and Li Guohua Injuries to Children With Attention Deficit Hyperactivity Disorder Pediatrics 1998;102;1415-1421
DOI:10.1542/peds.102.6.1415
22. Biederman J, Faraone S, Miberger S, et al
A Prospective 4-year Follow-up Study of Attention Deficit Hyperactivity and Related Disorders Arch Gen Psychiatry. 1996; 53:437-446
23. Wohlraich Mark L, MD; Wibbelsman Charles J, MD; Brown Charles J, PhD; Evans Steven W, PhD; Gotlieb Edward M; Knight John R, Ross Clarke E, Shubiner Howard H, Wender Esther and Wilens Timothy
Attention-Deficit/Hyperactivity Disorder among Adolescents: A Review of the Diagnose, Treatment, and Clinical Implications
Pediatrics 2005; 115; 1734-1746 DOI: 10.1542/peds.2004-1959
Methylphenidate and Cognitive Therapy: a Comparison of treatment Approaches with Hyperactive Boys
J Abnorm Child Psychol 1985;13:69-87 25. The MTA Cooperative Group
Moderators and Mediators of Treatment Response for Children with Attention Deficit Hyperactivity Disorder
Arch Gen Psychiatry, 1999;56;1088-1096
26. Subcommittee on Attention-Deficit / Hyperactivity Disorder and Committee on Quality Improvement
Clinical Practice guideline: Treatment of the School-Aged Child With Attention deficit / Hyperactivity Disorder
Pediatrics 2001; 108; 1033-1034 DOI: 10.15427peds 108.4.1033
27. Biederman Joseph, Heiligenstein John H, Faries Douglas E, Galilv, Dittemnn Ralf, Emslie Graham J, Kratochvil Christopher J, Laws Hary F and Schuh Kory J
Efficacy of Atomoxetine Versus Placebo in School-Age Girls With Attention-Deficit/Hyperactivity Disorder
Pediatrics 2002; 110;e75 DOI10.1542/peds.110.6.e75
28. Bymaster Frank P, M.S., Katner Jason S, B.S., Nelson David L, Ph.D., Hemrick-Luecke Susan K, M.S., Threlkeld Penny G, M.S., Heiligstein John H, M.D., Morin S. Michelle, M.S., Gehlert Donald R, Ph.D., and Perry Kenneth W, M.S.
Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
Neuropsychopharmacology 2002-Vol 27, N° 5
29. Biederman Joseph, Lopez Frank A, Boellner Samuel W and Chandler Mark C
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of SLI381 (Adderall XR) in Children With Attention-Deficit/hyperactivity Disorder
Pediatrics 2002;110;258-266 DOI:10.1542/peds.110.2.258
Gregory A, Onyango Adia N, Meichenbaum David L, Williams Andy, Aronoff Helen R and Steiner Randi L
A Comparison of Morning Only and Morning/Late Afternoon Adderall to Morning-Only, Twice-Daily, Three Times-Daily Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder Pediatrics 1999;104;1300-1311
DOI:10.1542/peds.104.6.1300
31. Pelham William E, Aronoff Helen R, Midlam Jill K, Shapiro Cheri J, Gnagy Elisabeth M, Chronis Andrea M, Onyango Adia N, Forehand Gregory, Nguyen Anh and Waxmonsky James
A Comparison of Ritalin and Adderall: Efficacy and Time-course in Children With Attention-Deficit/Hyperactivity Disorder
Pediatrics 1999;103;e43 DOI:10.1542/peds.103.4.e43
32. Efron Daryl, Jarman Frederik and Barker Melinda
Side Effects of Methylphenidate and Dexamphetamine in Children With Attention Deficit Hyperactivity Disorder: A Double Blind, Crossover Trial
Pediatrics 1997;100;662-666 DOI:10.1542/peds100.4.662 33. May DE, Kratchovil CJ
Attention-deficit Hyperactivity Disorder: Recent Advances in Paediatric Pharmacotherapy Drugs 2010;70(1):15-40
DOI: 10.2165/11530540-000000000-00000 34. Barkley R, Du Paul G, Mac Murray M.
Attention Deficit Disorder With and Without Hyperactivity: Clinical Response to Three Dose Levels of Methylphenidate
Pediatrics 1991;87:519-531
35. Ahmann PA, Waltonen SJ, Olson KA, Theye FW, Van Erem AJ, LaPlant RJ Placebo-Controlled Evaluation of Ritalin Side Effects
Pediatrics1993;91;1101-1106
36. Charach A, Ickowicz A, Schachar R
Stimulant Treatment over Five Years: Adherence, Effectiveness and Adverse effects J Am Acad Child Adolesc Psychiatry 2004;43.559-567
37. Vetter Viktoria L, MD; Ella Josephine, MD; Edckson Christopher, MD; Berger Stuart, MD; Blum Nathan, MD; Uzarh Karin, RN; Webb Catherine L,MD
Cardiovascular Monitoring of Children and Adolescents with Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder
American Heart Association Scientific Statement
Age of Methylphenidate Treatment Initiation in Children with ADHD and Later Substance Abuse:
Prospective Follow-up into Adulthood Am J Psychiatry. 2008;165(5):604-9
39. Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, Biederman J Effect of Prior Stimulant Treatment for Attention-deficit/Hyperactivity Disorder on Subsequent Risk for Cigarette Smoking and Alcohol and Drug Use Disorders in Adolescents
Arch Pediatr Adolesc Med. 2008;162(10):916-21
40. Spencer Thomas, Biederman Joseph and Wilens Thimothy
Growth Deficits in Children With Attention Deficit Hyperactivity Disorder Pediatrics 1998;102;501-506
DOI:10.1542/peds.102.2.S1.501
41. Sunohara Glen A, Ph.D., Malone Molly A, Ph.D., Rovet Joanne, Ph.D., Humphries Thomas, Ph.D., Roberts Wendy, M.D., and Taylor Margot J, Ph.D
Effects of Methylphenidate on Attention in Children with Attention Deficit Hyperactivity Disorder (ADHD): ERP Evidence
Neuropharmacology 1999-Vol 21, N° 2
42. Patrick KS, Straughn AB, Jarvi EJ, Breese GR, Meyer MC
The Absorption of Sustained-release Methyplphenidate Formulations Compared to an Immediate-release Formulation
Biopharm Drug Dispos. 1989;10(2):165-71
Name : First Name : Date of Birth
Date of introduction of IR : Dose of IR :
What is, according to you, the length of actin of IR ?
Compared to IR, SR seems:
- More efficient - Less efficient
- On which symptoms is it more or less efficient ?
Did teachers notice a different behaviour since introduction of SR ? If yes, which one ?
Did you notice any change in school results after introduction of SR ? If yes, which one ?
Compare SR to IR side effects - Appetite loss lunch : - Appetite loss dinner : - Sleeping disorder :
- Rebound effext afternoon : - Rebound effect evening : - Headaches :
- Abdominal pain :
Compared to IR, SR has following effects :
- more or less positive effect on attention/concentration deficit ? - more or less positive effect on impulsivity ?
- more or less positive effect on hyperactivity?
If yes, why ? If no, why ?
What does your child think about SR ?
How long has your child been under a SR trial ? What was your decision after the SR trial ?
- Keep your child under SR ? - Change dose of SR ? - A mixture of SR and IR ? - Put your child back on IR ?
Comments on SR :
Name : First Name : Date of Birth
Is ER the first medication introduced for treatment of ADHD ? If not, which treatment did he have before ?
- IR ? dose ? - SR® ? dose ? - IR + SR ? dose ?
Date of introduction of IR or SR ? Date of introduction of ER ? Actual dose of ER ?
Days of treatment of ER ? - Days of school ?
- Days of school and extrascolar activities ? - seven days a week ?
What time does your child take ER ?
Does your child have difficulties swallowing ER tablets?
After how much time does ER start acting ?
How long does ER act ?
Compared to IR or SR, does ER seem : - More efficient ?
- Less efficient ? - Same efficiency ?
What behavioural change in your child did you observe after the switch to ER?
What behavioural change in your child did teachers observe after the switch to ER?
What behavioural change did your child observe himself after the switch to ER?
Looking at behaviour, school results, relations with pairs /teachrs /family members, did ER bring any change ?
Compare side effects of ER compared to IR or SR : - Appetite loss lunch :
- Appetite loss dinner : - Sleeping disorder :
- Rebound effext afternoon : - Rebound effect evening : - Headaches :
- Abdominal pain :
Compared to IR or SR, ER is :
- more or less efficient on attention / concentration deficit ? - more or less efficient on impulsivity ?
- more or less efficient on hyperactivity ?
Are you satisfied by ER ? If yes, why ?
If no, why ?
Is your child satisfied by ER ?
How long was your child’s trial on ER ?
What did you decide after the ER trial : - Keep your child on ER ? - Change dose of ER ?
- Switch your child back to IR or SR ? - Stop any ADHD treatment ?
Comments on ER :